4/A: CareDx Director Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing
Richard Bryan Riggsbee, a director at CareDx, Inc., filed an amendment to a Form 4, correcting the exercise price of stock options acquired on June 13 and June 14, 2024.
Summary
- Richard Bryan Riggsbee, a director of CareDx, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the exercise price of stock options previously reported on the original Form 4 filed on June 17, 2024.
- The corrected filing details the acquisition of stock options on June 13, 2024, for 9,760 shares with an exercise price of $14.61.
- Additionally, it reports the acquisition of stock options on June 14, 2024, for 16,048 shares with an exercise price of $14.19.
- The options vest over time, with the first grant vesting monthly from April 11, 2024, through March 11, 2027, and the second grant vesting monthly from July 14, 2024, through June 14, 2025.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing correcting a minor error, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies like CareDx. It provides transparency into the holdings and transactions of company directors.
Key Dates
| Date | Description |
|---|---|
| 06/13/2024 | Date of earliest transaction: Acquisition of stock options for 9,760 shares. |
| 06/14/2024 | Acquisition of stock options for 16,048 shares. |
| 06/17/2024 | Date of original Form 4 filing. |
| 06/20/2024 | Date of amended Form 4/A filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.